Terms: = Brain cancer AND KLK2, P20151, 3817, ENSG00000167751, MGC12201, hK2, KLK2A2 AND Clinical Outcome
2 results:
1. Regulation of hk2 expression through alterations in CpG methylation of the hk2 promoter during progression of hepatocellular carcinoma.
Lee HG; Kim H; Son T; Jeong Y; Kim SU; Dong SM; Park YN; Lee JD; Lee JM; Park JH
Oncotarget; 2016 Jul; 7(27):41798-41810. PubMed ID: 27260001
[TBL] [Abstract] [Full Text] [Related]
2. Comprehensive analysis of glycolytic enzymes as therapeutic targets in the treatment of glioblastoma.
Sanzey M; Abdul Rahim SA; Oudin A; Dirkse A; Kaoma T; Vallar L; Herold-Mende C; Bjerkvig R; Golebiewska A; Niclou SP
PLoS One; 2015; 10(5):e0123544. PubMed ID: 25932951
[TBL] [Abstract] [Full Text] [Related]
